All drugs

Arsenic trioxide is a chemotherapeutic agent used in the treatment of refractory or relapsed acute promyelocytic leukemia in patients with prior retinoid and anthracycline chemotherapy.

Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors.

Indications for Use

Azacitidine (for subcutaneous or intravenous administration) is indicated for the treatment of adult patients with the following subtypes of French-American-British (FAB) myelodysplastic syndrome (MDS): refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (in the presence of neutropenia or thrombocytopenia, as well as in the presence of transfusion requirements), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMML). Azacitidine is also indicated for the treatment of children 1 month of age and older with newly diagnosed juvenile myelomonocytic leukemia (JMML).

Dosage 15 mg price 220$

 Colorectal cancer

 Lansurf is indicated as monotherapy for adult patients with metastatic colorectal cancer who have previously undergone or are ineligible for existing therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, as well as anti-VEGF and anti-EGFR agents.

 Gastric cancer

 Lansurf is indicated as monotherapy for adult patients with metastatic gastric cancer, including patients with gastroesophageal junction adenocarcinoma, who have previously received at least two systemic therapies at disease progression.